inventories of THB 30.72 million or 1% of the total assets, a slight increase of THB 2.47 million compared to the last year due to increase of packaging and raw material for restaurant business. o Investment in
to investors in private placement, the acquisition of assets and convening the Extraordinary General Meeting of the Shareholders No. 1/2018 (Revise) To : President, The Stock Exchange of Thailand
, the sale of gravure packaging of rice industry also reduces. The company have a trends to solve the problem by trying to increase the order from Pet food industry instead. On the contrary, sales of
9.33 85.51 9.05 9.12 10.67 Total Revenue from Sales and Services 1,011.54 99.70 940.57 99.57 70.97 7.55 Gain on Sales of Fixed Assets 0.05 - - - 0.05 - Gain on Foreign Exchange Rate – Net 0.85 0.08 1.41
financial status of the Company and its subsidiaries as of June 30, 2019 with the comparison to the financial status as of December 31, 2018 are summarized as below: Assets As of June 30, 2019, the Company
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
and EP dated 31 July 2020 are satisfied in order to be the transferee of the all sale shares of RPV. In this regard, such transaction is deemed to be a disposal of assets under the notification of the
selling expenses from new packaging launch for some branded product; 6) higher administrative expenses from higher personnel expenses; 7) higher R&D expenses; 8) higher finance costs due to higher
0.29 3.08 Net profit (loss) (0.07) 0.19 11.58 * Other income included revenue from sales of finished products, packages, packaging services, interest income and gain on disposal of assets. Statements of
income included revenue from sales of finished products, packages, packaging services, interest income and gain on disposal of assets. บริษัท ดีโอดี ไบโอเทค จ ำกัด (มหำชน) 111 หมู่ท่ี 2 ต ำบลท่ำจนี อ ำเภอ